Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank100
Studio
Year-over-Year Change

Return on invested capital

Latest
-13.56%
↑ 76% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-56.88%
Historical baseline
PeriodValueYoY Change
2025-13.56%+52.3%
2024-28.41%+48.4%
2023-55.05%-56.7%
2022-35.13%-68.5%
2021-20.84%+85.0%
2020-139.33%-31.6%
2019-105.85%-